Rivaroxaban in acute venous thromboembolism: UK prescribing experience
Abstract Background Rivaroxaban was reported as effective as traditional therapies for the acute treatment of venous thromboembolism (VTE) with fewer major bleeding complications in the seminal Einstein program and is now a recommended option for the treatment of VTE around the world. Objective To r...
Main Authors: | Victoria Speed, Jignesh P. Patel, Derek Cooper, Stephen Miller, Lara N. Roberts, Raj K. Patel, Roopen Arya |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-10-01
|
Series: | Research and Practice in Thrombosis and Haemostasis |
Subjects: | |
Online Access: | https://doi.org/10.1002/rth2.12607 |
Similar Items
-
Adherence to rivaroxaban for the treatment of venous thromboembolism–Results from the FIRST registry
by: Victoria Speed, et al.
Published: (2021-12-01) -
Pooled Analysis of Rivaroxaban therapy for acute venous thromboembolism in FIRST registry, SWIVTER and DRESDEN NOAC registry
by: Stephanie Müller, et al.
Published: (2022-10-01) -
Fatigue after initiating rivaroxaban for venous thromboembolism
by: Tina Margrethe Karlsvik, et al.
Published: (2020-05-01) -
THE ADVANCED TACTICS OF THE MANAGEMENT OF PATIENTS WITH VENOUS THROMBOEMBOLISM: THE ROLE OF RIVAROXABAN AT VARIOUS STAGES OF TREATMENT
by: S. R. Gilyarevskiy
Published: (2016-06-01) -
A study on the role of rivaroxaban in management of venous thromboembolism
by: Mohmed Abdalwahab, et al.
Published: (2015-10-01)